“…A recent report of seven patients with recalcitrant orbital myositis, previously treated with steroids and either radiotherapy or other anti-inflammatory medications, documented clinical response in all patients to infliximab therapy. 112 Underlying disease associations in these patients included Crohn's disease (n ¼ 2), Behcet's disease (n ¼ 1), and psoriasis (n ¼ 1) and the mean follow-up for response was 15.7 months, with a range of 4-31 months. Other case reports have documented therapeutic responses in Churg-Strauss syndrome and myositis.…”